I-NIH Ukuqashwa kwezigulane ze-Hypothyroid kwi-Study New
Ngumhla wokuthabatha izigulane ze-thyroid, kunye neyilindelwe ixesha elide. I-Institutes National Health Institute yase-United States iye yazisa ukuba uvavanyo lwekliniki luqaliswe ngo-2012 kwiziko lezeMpilo lezeMpilo laseWalter Reed, eBetdada, MD, ukufundela izidakamizwa zemvelo ze-thyroid ngokubhekiselele ku-levothyroxine, ukwenzela unyango lwe-hypothyroidism eyintloko.
Uphononongo olungapheliyo, oluqhubela phambili-oluya ngoMeyi ka-2014 - luya kuhlola i-hypothesis yokuba izigulane ze-hypothyroid kwi-thyroid echongiwe yendalo (into ebhekisela kuyo ngokuthi "i-extractedroidroid extract" okanye i-DTE) inokuba "nokuhla kweempawu, ukuphuculwa komsebenzi wokuqonda, kunye nokwanda kwimeko yokuphila / umgangatho wobomi , "xa kuthelekiswa ne-levothyroxine.
Isihloko esisemthethweni sophando "Sichazwe ngeTroid Extract Comparated to Levothyroxine kwiNyango ye-Hypothyroidism : Isifundo esiPhezulu esiPhezulu, esiPhezulu-mbumbulu," kwaye bafumana izigulane ze-thyroid njengabantu abathatha isifundo.
Ukufaneleka
Unelungelo lokuthatha inxaxheba kulolu cwaningo ukuba ungumntu okanye umfazi, phakathi kweminyaka eyi-18 no-65 ubudala. kwaye sele i-levothyroxine ye-hypothyroidism eyimfuneko ubuncinane ubuncinane kwiinyanga ezili-6. (QAPHELA: Amalungu asebenzayo kuphela okanye asele umhlalaphantsi emkhosini kunye nabaxhamli babo bayafaneleka kulolu vavanyo.)Ezingabikho
Uyakukhutshwa ngaphandle kwesi sifundo ukuba unayo na le miqathango okanye imiba elandelayo:- ukukhulelwa okanye isicwangciso sokukhulelwa kwiinyanga ezili-12 ezizayo
- isifo senhliziyo , ngokukhethekileyo isifo somgulo we-coronary
- isifo esingapheliyo sokukhupha umphunga
- ingxaki yokugula
- utyando lomzimba
- utywala obunzima okanye ubungozi besibindi
- ukuphazamiseka kwengxaki
- umdlavuza we-thyroid kunye non-thyroid
- kwengqondo engalawulekiyo
- ukusebenzisa iyeza zengqondo
- ukusebenzisa i-steroid
- ukusebenzisa i-amiodarone
- i-chemotherapy yomhlaza
- insimbi yongeza ngaphezu kwama-325mg ngosuku
- ukusebenzisa i-carafate / proton pump inhibitor
- benzisa i-cholestyramine
Kutheni le Mvavanyo ibalulekile?
Eli lilingo lubalulekile kuba lixesha lokuqala kwimbali yembali yokuba ndiyazi ukuba iqumrhu lophando lwezobugqirha eliye laziwa ngamazwe - kule meko, i-US National Institutes of Health - iqhuba uphando-mbumbulu, uphonononge uphando impawu, umsebenzi wokuqonda, ukuphila kakuhle, kunye nomgangatho wobomi kwizigulane ze-hypothyroid kwizilwanyana zonyango ezichongiweyo zendalo, ngokubhekiselele kwi-levothyroxine eqhelekileyo.Olu vavanyo lukwabalulekile kuba kukho ukunyaniseka okukhulu phakathi kwama-endocrinologists aqhelekileyo ekuchaseni izidakamizwa ze-thyroid ezichongiweyo zendalo, kodwa akusekelwe kuphando, kodwa kunoko, iimbono zabo kunye nezinto ezithandayo. Eminye i-endocrinologists, eneneni, sele ithe i- thyroid yezilwanyana ezinjengezixhobo zempahla zithathwa kuphela "ngomphetho" , nangona ukuba imimiselo engaphezu kwezigidi ezibini zezi bhali zibhalwa minyaka yonke eUnited States yedwa, kunye nangaphezulu hlabathi.
Olu vavanyo lubalulekile ngenxa yokuba sifuna uphando olujongene ngqo nokusetyenziswa kwe-thyroid eyenziwe yendalo. Ezinye izifundo, kubandakanywa nophando lwesiDanishi ka - 2009 , zibonise imilinganiselo yokuphucula ubomi kunye nokudibanisa kwe-T3 yokwenziwa kohlobo lwe -T4 (levothyroxine), kodwa abanye oogqirha baye bathetha ukuba ezi zifundo azichaphazelekayo xa ziqwalasela izidakamizwa zemvelo zonyango (eziqhelekileyo ziqulethe zombini T3 kunye ne-T4 ) kuba ziziyobisi ezahlukeneyo.
Ukuthatha inxaxheba kwi-Trial
Ukuba uhlangabezana neziqinisekiso kwaye unomdla wokubanjelwa ukuba uthathe inxaxheba kulolu vavanyo lwekliniki, qha ga mshelana: Mohamed Shakir, MD, 301-295-5165, mohamed.shakir@med.navy.mil kunye noPatrick Clyde, MD, 301-295- 5165, patrick.clyde@med.navy.mil.Inombolo ye-kliniki ye-Trials.gov yolu vavanyo yi-NCT01739972.
Uyabona uluhlu olupheleleyo lweClinikiTrials.gov.